SEI Investments’s Niagen Bioscience NAGE Stock Holding History
Bought
Maintained
Sold
Other funds holding NAGE
SW
TCM
SEI Investments's NAGE Position: Q2 2026 in Review
SEI Investments reduced its Niagen Bioscience (NAGE) stake by 51% in Q2 2026, selling an estimated $2.03M and leaving 471,934 shares worth $1.51M. The position accounts for ﹤0.01% of the portfolio, ranked #2097.
SEI Investments first reported a position in NAGE in Q2 2025 and has held it in 5 quarters since. The position peaked at $4.28M in Q1 2026. 140 funds tracked by Wall St. Rank hold NAGE as of Q2 2026.
- SEI Investments held 471,934 shares of Niagen Bioscience worth $1.51M as of Q2 2026.
- SEI Investments sold 499,640 Niagen Bioscience shares in Q2 2026, an estimated $2.03M.
- Niagen Bioscience made up ﹤0.01% of SEI Investments's portfolio in Q2 2026, its #2097 holding.
- SEI Investments first reported a position in Niagen Bioscience in Q2 2025 and has held it in 5 quarters since.
- SEI Investments's Niagen Bioscience position peaked at $4.28M in Q1 2026.
- 140 funds tracked by Wall St. Rank held Niagen Bioscience as of Q2 2026.
Based on SEI Investments's 13F filing for Q2 2026, filed 14 Aug 2026.